Volume 6, Number 4—August 2000
Neisseria meningitidis Serogroup W135 Isolates Associated with the ET-37 Complex
To the Editor: As of April 20, 2000, >300 laboratory-confirmed cases of meningococcal disease caused by N. meningitidis serogroup W135 (NMW135) have been reported in Saudi Arabia and nine other countries among Hajj pilgrims or their close contacts (1). This is the first multinational outbreak of W135 meningococcal disease. NMW135 accounts for <5% of meningococcal disease in the United States and worldwide. The main cause of meningococcal disease outbreaks, especially in the African "meningitis belt," which extends from Ethiopia in the east to Senegal in the west, has long been N. meningitidis serogroup A. An epidemic, caused by a particular clonal group of serogroup A, identified by multilocus enzyme electrophoresis (MEE) as subgroup III-1, occurred in Nepal (1983 and 1984), Pakistan and India (1985) (2) and may have caused earlier epidemics in China. In 1987, an outbreak of group A meningococcal disease caused by the same clonal group occurred in association with the annual Moslem pilgrimage to Mecca (Hajj) (3). At that time, Saudi Arabia implemented vaccination requirements for all entering pilgrims. The vaccine formulations vary; bivalent A/C vaccine or quadrivalent A/C/Y/W135 vaccine (as licensed in the United States) is used.
We present molecular characterization results of NMW135 isolates from four U.S. patients with meningococcal disease. These cases were epidemiologically linked to this year's Hajj in Saudi Arabia that concluded on March 17, 2000 (4). We examine the origin and potential relatedness of the NMW135 isolates to some of the major N. meningitidis virulent clones. Two patients (both vaccinated with quadrivalent A/C/Y/W135 vaccine) were returning pilgrims; one was a close household contact of another pilgrim, the other had other possible contacts with the U.S. pilgrims. Three isolates were identified as NMW135 at the New York City Health Department and the fourth at the California Department of Health. Serogroup identification was confirmed at the Centers for Disease Control and Prevention by standard microbiologic methods (CDC) (5).
MEE has long been the standard method for molecular subtyping of N. meningitidis and has allowed identification of several major epidemic-prone clones. When the MEE system established by Caugant et al. (6) and that used at CDC were recently compared, they demonstrated excellent correlation segregating individual electrophoretic types (ETs) into similar clusters. A virulent clone, designated ET-37 complex, which contains >50 different ETs, is mainly composed of N. meningitidis serogroup C. In the United States, strains of ET-24 (within the ET-37 complex) are the main cause of meningococcal disease outbreaks and among the most frequent causes of sporadic meningococcal disease (7). The four Hajj-associated NMW135 isolates were of ET-927, which is located in a small cluster more closely related to the ET-37 complex (at a genetic distance <0.20) than to any other NMW135 isolate or any other major virulent clonal group among >2,000 N. meningitidis isolates in our collection (8). This cluster contains two other NMW135 isolates: one from Indonesia from a pilgrim returning from the 1996 Hajj and another from Canada (1997) for which additional epidemiologic information is not available.
Serotyping and serosubtyping showed that all four W135 isolates were 2a:P1.5,2, most frequently seen in N. meningitidis serogroup B and C isolates (9). Sequencing of the variable regions (VR) of the porA gene showed that these four isolates had VR1 and VR2 sequences identical to those of the prototype P1.5,2 strain. Strains of the same serogroup/serosubtype have been already identified in France and the Netherlands isolated from four patients with Hajj 2000 association (1), and earlier in Gambia (1990-1995) and Mali (1995) (10). A single NMW135 isolate from Gambia and one from Mali are listed in the multilocus sequence typing (MLST) database (Oxford database) as being of sequence type 11, typically seen in isolates of the ET-37 complex (11). MLST provides results comparable to those of MEE for classification and taxonomic purposes. We are evaluating the usefulness of MLST for outbreak studies. The DNA sequences of the 16S rRNA gene of the four Hajj-associated NMW135 isolates were identical to each other and to those of the California (1995) outbreak-related serogroup C ET-24 strains and an Ohio (1997) sporadic serogroup C ET-24 strain. The 16S rRNA gene sequences of 66 N. meningitidis isolates representing serogroups A, B, C, W135, Z, and Y were diverse, with nine different sequences among the NMW135 isolates. Finally, all four recent NMW135 isolates had identical NheI pulsed-field gel electrophoresis (PFGE) patterns distinct from patterns seen in other NMW135 isolates. All these molecular markers were clearly unique in NMW135 isolates previously identified in the United States or isolated at the same time as the Hajj-associated isolates but with no epidemiologic link to the current outbreak. These unique markers allowed easy differentiation of the imported, Hajj-associated isolates from other sporadic NMW135 isolates circulating in the United States.
It has been shown previously that NMW135 strains can exist in widely divergent clonal groups. Our data suggest that strains like those associated with this year's Hajj have been in circulation in human populations for at least several years in different parts of the world. Given that the Hajj is a large, yearly event, high-level exposure of pilgrims to respiratory secretions and subsequent spread of infection to many countries by returning pilgrims may turn W135 meningococcal disease into a global health threat. Continued surveillance, as well as increased awareness of meningococcal disease caused by N. meningitidis of this serogroup by physicians and the public, is needed. Efforts to measure the efficacy of the quadrivalent meningococcal vaccine for prevention of W135 meningococcal disease should be considered. To get a better global understanding of W135 meningococcal disease, we are conducting a large multicenter study on molecular characterization of >50 Hajj-associated NMW135 isolates from Saudi Arabia, France, Singapore, and Finland, and 50 other W135 isolates from throughout the world.
- Samuelsson S, Handysides S, Ramsay M, Lyytikainen O, Nygard K, Perrocheau A, Meningococcal infection in pilgrims returning from the haj: update from Europe and beyond. Eurosurveillance Weekly. 2000;17:1–5.
- Achtman M. Molecular epidemiology of epidemic bacterial meningitis. Rev Med Microbiol. 1990;1:29–38.
- Novelli VM, Lewis RG, Dawood ST. Epidemic group A meningococcal disease in Haj pilgrims. Lancet. 1987;2:863.
- Centers for Disease Control and Prevention. Serogroup W135 meningococcal disease among travelers returning from Saudi Arabia--United States, 2000. MMWR Morb Mortal Wkly Rep. 2000;49:345–6.
- Popovic T, Ajello G, Facklam R. Laboratory manual for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. Geneva: World Health Organization; 1999.
- Caugant D. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS. 1998;106:505–25.
- Rosenstein NE, Perkins BA, Stephens D, Lefkowitz L, Cartter ML, Danila R, The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis. 1999;180:1894–901.
- Reeves MW, Perkins BA, Diermayer M, Wenger JD. Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis. Emerg Infect Dis. 1995;1:53–4.
- Sacchi CT, Lemos APS, Brandt ME, Whitney AM, Melles CAE, Solari CA, Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin Diagn Lab Immunol. 1998;5:845–55.
- Kwara A, Adegbola RA, Corrah PT, Weber M, Achtman M, Morelli G, Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health. 1998;3:742–6.
- Maiden MCJ, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998;95:3140–5.
Suggested citation: Popovic T, Sacchi CT, Reeves MW, Whitney AM, Mayer LW, Noble CA. Neisseria meningitidis Serogroup W135 Isolates Associated with the ET-37 Complex [letter]. Emerg Infect Dis [serial on the Internet]. 2000, Aug [date cited]. Available from http://wwwnc.cdc.gov/eid/article/6/4/00-0423
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 16, 2010
- Page last updated: December 16, 2010
- Page last reviewed: December 16, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)